Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287022 · ClinicalTrials.gov registry record
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
A clinical trial of Primary Ciliary Dyskinesia, sponsored by Arkansas Children's Hospital Research Institute.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05287022 is a study of Primary Ciliary Dyskinesia that is actively recruiting participants, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 150 participants, above the 89-participant average among 7 other Primary Ciliary Dyskinesia trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05287022, a study of Primary Ciliary Dyskinesia, is actively recruiting participants, sponsored by Arkansas Children's Hospital Research Institute.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.
Conditions Studied
Study Locations (1)
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2030-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287022
The ClinicalTrials.gov registry entry for NCT05287022 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 89-participant average among 7 other Primary Ciliary Dyskinesia trials with a reported enrollment target (69% higher). The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Ciliary Dyskinesia appearing as the primary indexed condition, and to 0 interventions.
NCT05287022 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT05287022 about?
NCT05287022 is a clinical study titled "Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care". this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make...
What is the current status of trial NCT05287022?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-06-14. Estimated completion is 2030-06.
What conditions does trial NCT05287022 study?
This clinical trial studies the following conditions: Primary Ciliary Dyskinesia.
Who is sponsoring clinical trial NCT05287022?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287022 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Ciliary Dyskinesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Utility of PCD Diagnostics to Improve Clinical Care
RECRUITING · NA
-
Utility of PCD Diagnostics to Improve Clinical Care
RECRUITING
-
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
ACTIVE NOT RECRUITING
-
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
ACTIVE NOT RECRUITING
-
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.